Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4536-1 (MIR4536-1) is a human microRNA gene that produces a small, non-coding RNA transcript involved in post-transcriptional regulation of gene expression. Like other microRNAs, MIR4536-1 is processed from a primary transcript into a mature miRNA that incorporates into the RNA-induced silencing complex (RISC) to guide the silencing of specific mRNA targets, thereby regulating protein synthesis. MIR4536-1 has been implicated in the regulation of neuronal differentiation, influencing signaling pathways such as Wnt and MAPK. While microRNAs are broadly implicated in diseases including cancer and neurodegeneration, the specific disease associations and clinical relevance of MIR4536-1 require further research. MIR4536-1 is not a conventional pharmacological target (such as a receptor or enzyme), but may be considered an emerging target for oligonucleotide-based modulation in experimental settings.
MicroRNAs downregulate target mRNAs via RNA-induced silencing, leading to mRNA degradation or translational repression. If therapeutically targeted, mechanisms would involve post-transcriptional gene silencing via RNA-induced silencing complex (RISC) or antisense inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4536-1 (MIR4536-1).